CLL2 and CLL3 Trials

The CLL2 and CLL3 trials are clinical studies focused on treating chronic lymphocytic leukemia (CLL), a type of blood cancer. CLL2 evaluated the efficacy of a specific chemotherapy regimen, while CLL3 tested the combination of chemotherapy and immunotherapy. Both trials aimed to determine how effective these treatments were in improving patient outcomes, such as survival rates and quality of life. Results from these studies contribute valuable insights to help doctors choose the best treatment options for patients with CLL.